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ABSTRACT
The aim of the Te Mata Ira project was to explore Māori views on biobanking and genomic research, and 
to identify ways to address Māori concerns over the collection and use of human tissue. Key informant 
interviews and workshops were conducted with Māori to identify Māori views in relation to biobanking and 
genomic research; and, informed by these views, interviews and workshops were conducted with Māori and 
non-Māori key informants (Indigenous Advisory Panel (IAP) members and science communities) to explore 
key issues in relation to Māori participation in biobanking and genomic research. Māori key informants 
identified the following as key deliberations: (1) the tension for Māori between previous well-publicised 
negative experiences with genomic research and the potential value for whānau and communities as 
technologies develop, (2) protection of Māori rights and interest, (3) focus on Māori health priorities, (4) 
control of samples and data, (5) expectations of consultation and consent and (6) a desire for greater 
feedback and communication. Māori and non-Māori key informants highlighted the need to enhance levels 
of Māori participation in the governance of genomic research and biobanking initiatives, and acknowledged 
that only by increasing the level of transparency and accountability in relation to these activities will Māori 
communities feel that their whakapapa, rights and interests are being appropriately protected.
Māori have been contributing to the 
debates about research ethics1–3 and 
genetics4–8 for a number of years. Several 
studies exploring Māori views on genetic 
research9–13 and biobanking14,15 have 
described Māori perspectives on these types 
of research and the key issues that arise, 
including cultural issues,16,17 governance 
issues,18,19 consent processes,20 social equi-
poise,21,22 distribution of risks and benefi ts,2,23 
tissue storage,16,24 analysis10,23 and interpre-
tation of results.10,20,23 
Te Ara Tika—Guidelines on Māori Research 
Ethics: A framework for researchers and 
ethics committee members2 established a 
framework for understanding the diverse 
views that inform Māori ethical deliber-
ations and noted the heightened ethical 
sensitivities that exist for Māori in relation 
to the use of tissue and genetic infor-
mation. However, the document did not 
provide substantive comment or practical 
advice for genetic researchers or biobanks 
in relation to Māori cultural, ethical and 
legal parameters for these activities. Māori 
continue to consent for their tissue to be 
used in biomedical research projects,4,10,11,13 
so it is important that their expectations of 
ethical research behaviour are refl ected 
in developing guidelines. The Te Mata 
Ira research project explored the issues 
that Māori encounter when they choose 
to be involved in genomic research and 
biobanking with the aim of providing more 
substantive culturally appropriate guidance 
to researchers and communities alike.
Background
Genomic research represents a new 
frontier for health research and provides a 
platform for personalised medicines (phar-
macogenomics). The scale of biological 
samples required to adequately power 
genomic studies has led to signifi cant 
growth, nationally and internationally, of 
both biobanks and genomic databases.25–29 
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Though genomic research has yet to fulfi l 
the promise of personalised medicine, 
ethical discussions within Māori commu-
nities4,9,11,30 and among ethicists in the 
international domain31–34 are evolving 
to meet emerging challenges and tech-
nologies. Subsequently, there has been a 
proliferation of international genetic data-
bases25,35 and national34,36 and international 
guidance documents37–39 suggesting various 
ways for governing them. Yet commer-
cialisation practices and the return of 
individual results varies.14,28 Nevertheless, 
it is vital to include Indigenous ethical 
principles in genomic research, particularly 
given the existing storage of Indigenous 
genetic material and because it is possible 
that genomics could play a role in future 
contests over Indigenous people’s claims of 
identity and rights.40–42 
Ethical controversies surrounding genetic 
studies, like the human genome diversity 
project, 23 the ‘warrior gene’43,44 and the 
Arizona State University settlement with 
the Havusupai, a Native American tribe,45 
have prompted Indigenous critiques. These 
have included research by Indigenous 
Peoples Council on biocolonialism about 
the Havasupai15,46–48 and work undertaken 
by the National Congress of American 
Indians (NCAI) studying views of genetic 
health research in Indian Country.15,49–51 
Researchers are also recognising the need 
for change, and a recent Nature Reviews 
Genetics paper by Gottweis, Chen52 called 
for biobanks to address issues of trust, 
benefi t sharing, data security, privacy and 
practicing reciprocity.
The use of biobanks and sharing of 
research data across projects are also being 
discussed in New Zealand as a cost-saving 
measure, particularly in relation to a 
number of high-cost medicines associated 
with cancer treatment. In the past two years 
the Health Research Council of New Zealand 
(HRC) Ethics Committee was approached for 
guidance on both secondary and unspec-
ifi ed future use of data and human tissue 
as well as appropriate use of information 
databases, prompting the HRC to consider 
developing a data-sharing policy. Recent 
research by New Zealand’s Virtual Institute 
of Statistical Genetics has also shown that 
sample sizes of 1,000,000—10,000,000 are 
needed to obtain suffi  cient evidence for 
association, meaning extensive data sharing, 
including that relating to Māori genetic 
material, is required for genome-wide asso-
ciation studies.26 In many instances the data 
being shared will be based on biological 
samples (genetic/genomic information) 
and pressure is increasing for anonymous 
datasets be placed in the public domain as 
a prerequisite for publication. Similarly, the 
linking of computerised medical records 
with genetic/genomic information and 
population-level genome sequencing is also 
on the horizon. 
The speed of technological advance is 
outpacing the development of ethical over-
sight and it is apparent that in New Zealand 
much of the guidance on genetic research 
and data sharing is not specifi c enough to 
deal with emerging ethical issues associated 
with the types of genomic research now 
possible. The recent establishment of the 
Auckland Regional Tissue Bank (Auckland), 
Rare Diseases Tissue Bank (Dunedin), 
Melanoma Tissue Bank (Dunedin) and 
the Centre for Brain Research Biobank 
(Auckland) illustrate a shift towards devel-
oping more formal tissue storage facilities 
and the provision of more transparent 
consent processes for the ongoing use of 
tissue in research including genetic and 
genomic studies. 
Methods
Three sets of participants contributed 
views to gain understanding about the 
genomic research and biobanking contexts, 
how Indigenous populations have fared in 
these contexts and strategies to regulate 
these contexts. Semi-structured interviews 
were held with seven Te Mata Ira Inter-
national Advisory Panel (IAP) members 
until saturation was achieved. The panel 
members, who belong to Indigenous 
communities in Australia, Hawaii, Canada, 
US and New Zealand, represent a diverse 
range of research expertise in Indigenous 
health, health policy, medical genomics 
and bioinformatics. Given their diverse 
locations, IAP members were interviewed 
by telephone or skype. Five stakeholder 
workshops were conducted at Auckland, 
Christchurch and Dunedin (n=5). Two 
were science focussed workshops aimed at 
genetic researchers and biobank personnel 
(n=27, both Māori and non-Māori), and three 
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were Māori focussed workshops to gain 
views from Māori who have a role in health 
research, ethics or genetics (n=31). 
The three key questions asked in the inter-
views and workshops were;
1. Why should Māori/Indigenous 
communities participate in 
biobanking and/or genomic research?
2. What are the key issues for Māori/
Indigenous participation in 
biobanking and genomic research?
3. How might we address these issues?
The interviews and workshops were 
digitally audio-recorded, transcribed and 
summarised. Summaries were checked with 
IAP members to enhance validity. A guided 
thematic analysis—the process of coding 
empirical material to the research questions 
and emerging themes53,54—was conducted 
across several key domains, including but 
not limited to potential benefi ts of partic-
ipation, barriers to participation and 
expectations of behaviour. Answers to the 
fi rst and second questions are detailed 
below. Because key informants answered 
question three while discussing issues 
prompted by question two, these fi ndings 
are presented together. 
Findings
Why should Māori participate in 
biobanking and genomic research? 
The question of whether it is useful or 
appropriate for Indigenous/Māori commu-
nities to engage with new technologies 
continues to be the subject of discussion 
and debate. The views advanced by the 
three groups of participants refl ect a wide 
range of opinions on the value of partici-
pation in genomic research and biobanking 
initiatives. The key opportunities outlined 
by participants provided by engaging in 
genomic research and biobanking are the 
potential;
1. to derive health outcomes
2. to increase understanding and trust in 
the science and scientists
3. to improve processes of research
4. to protect broader interests of the 
Māori community
5. to realise other opportunities
Potential health outcomes were described 
largely in relation to lessening the inci-
dence and prevalence of disease, along 
with recognising that genomic medicine 
may be another type of health care that 
Māori communities can benefi t from. 
Māori key informants considered the 
value of participation in two distinct ways, 
namely, individual value and community 
value. At an individual level, key infor-
mants spoke about the potential to enhance 
health outcomes for the individual seeking 
treatment and expressed a keen sense of 
altruism in wanting to be part of some-
thing that they believed may help others 
outside of their immediate family. Māori 
participation in genomic research was also 
described by some as a potential tool for 
reducing inequalities but only if it is applied 
at both the individual and the community 
levels in an appropriate manner, along 
with a clear understanding of the limita-
tions of genomic research. The optimism 
about potential health gains was balanced 
by a recognition that genetic contributions 
towards health outcomes are only part of 
the answer and will be situated within a 
broader context of social determinants. 
What is the ethical balance between doing 
genetic research and what we know about the 
impacts of inequalities and poverty? (Māori 
key informant, workshop) 
The perceived link between enhanced 
treatment for disease and participation 
in genomic research was particularly 
pronounced in the discussion within the 
science workshops. Key informants in 
the science workshops explained that the 
current limited evidence on genetic vari-
ation between Māori tissue and other 
populations provides a unique opportunity 
and motivation for scientists to work with 
these communities in biomarker discovery. 
Māori participation is also seen as necessary 
to provide representative population wide 
data, something necessary to ensure that 
Māori communities directly benefi t from 
genomic medicine in the future. Along 
with other limitations, Māori would only 
benefi t if there were suffi  cient numbers of 
Māori participants and statistical power for 
Māori specifi c analyses to be conducted. 
Key informants in the science workshops 
also suggested increasing Māori samples 
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in biobanks would provide greater oppor-
tunities for Māori specifi c health priorities 
to be researched. They noted that Māori 
participation in genomic research and 
biobanking projects would require a greater 
level of trust in the people and processes 
responsible for the storage and use of 
tissue samples, as well as a greater level of 
transparency and culturally appropriate 
engagement from scientists.
Participation as a potential opportunity 
and facilitator of other community devel-
opment and capacity building initiatives 
was also discussed. The benefi ts described 
included those arising through greater 
control such as ownership of intellectual 
as well as biological property, and were 
described in a way that strategically 
positions Indigenous communities as 
decision-makers including supporting aspi-
rations for sovereignty. 
Key informants also felt that it is 
important to consider the factors that 
motivate whānau to get involved in genetic 
research and how this impacts on their 
ability to ask critical questions about the 
nature of the project. Families with genetic 
concerns participate in the interest of their 
family’s health as their primary focus is 
coping with the condition not how their 
genetic data might be used in the future.
If I’ve got it then I want my kids to be 
protected [from the disease] so it was a real 
whakapapa thing. It wasn’t a raced based, 
community based, [or] Iwi based thing at 
all. They did it [genetic testing] because they 
thought, “If I have something genetically 
wrong and my kid inherits it…then I want 
my kid to know that and for that to drive 
practice” (Māori key informant, workshop).
Generally, the key informants that partic-
ipated in the science workshops were more 
positive about the value of Māori partici-
pation in biobanking and genomic research 
in terms of improving the science and 
ensuring outcomes from research benefi t 
Māori. The Indigenous Advisory Panel 
and the key informants at the Māori work-
shops were more reticent about the value 
of participation but recognised it has direct 
benefi t for specifi c individuals and families, 
and that other collective interests could be 
addressed if Māori were more involved in 
governance and decision making to ensure 
the wider health benefi ts are realised.
What are the key issues related to 
Māori participation in biobanking 
and genomic research?
Protection of Māori rights and 
interests
Key informants described a legacy of 
mistrust created by examples of unethical 
engagement with Indigenous peoples 
in biomedical research, and this moti-
vates Māori to evaluate genomic research 
projects with a greater degree of scrutiny. 
Māori research principles promoting 
community participation, culturally appro-
priate protocols and Māori involvement in 
research and governance provide the foun-
dation for sound partnerships and quality 
research. Key informants spoke about the 
need to protect Māori interests through 
Māori control promoting concepts of power-
sharing over benefi t-sharing.
We’ll get this right if we know that the 
control sits with Māori. Not individual Māori 
because actually that’s a personal decision 
that they’re making based on a personal 
perspective…But this stuff has to occur on a 
much bigger scale and it has to be able to shift 
this down [to the level of Māori community] 
otherwise it’s of no value (Māori workshop).
Focus on Māori and Indigenous 
health priorities 
Key informants questioned whether 
genomic research is what is needed to 
change negative health outcomes for Māori. 
Key informants recognised the usefulness 
of genetic information for some conditions; 
however, they were less convinced of its 
utility for key Māori health priorities—like 
diabetes or cardiovascular disease—where 
multiple genes and environmental factors 
contribute to its expression. If health 
status is considered within a determi-
nants of health framework then there are 
other places you would put resources to 
address environmental and systemic factors 
impacting on individuals and populations. 
Key informants in the Māori workshops 
generally thought that prioritising funding 
for genomic research would divert resources 
away from public health research, which 
they believe had more immediate benefi ts 
for Māori communities.
They’ve got this information that they 
might have this gene contributing to 
whatever disease but then what do they do 
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with that information? How can they use that 
to improve health? (Key informant interview). 
We are at the intervention stage in public 
health. So when you’re putting resources 
into this unknown area when we’ve got 
all this mahi that we should be doing [it 
is mismatched] (Key informant, Māori 
workshop).
Robustness of genetic research 
methods
A number of the key informants had high 
levels of research expertise and were able 
to critique the framing and methods used in 
specifi c genomic research projects. Some of 
the concerns expressed include; 
a) the construction of racial or ethnic 
groupings for genetic comparisons, 
b) the attribution of familial character-
istics to larger groupings, 
c) the analysis and interpretation of 
results and 
d) an interest in the scientifi c novelty 
rather than clinical application. 
Inappropriate interpretation of results, as 
occurred with the ‘Warrior Gene’ hypothesis 
where polymorphisms in the monoamine 
oxidase A gene, were linked to aggressive 
behaviour in Māori, stigmatised the Māori 
community and reinforced negative 
stereotypes of researchers.20,55 One of the 
key challenges for genomic researchers 
when communicating results of genetic 
studies in specifi c ethnic populations is 
to ensure people understand that the use 
of the group to help identify a functional 
genes or phenotype does not mean that the 
phenotype is an ethnic marker, that is, a 
Māori gene. As a key informant in one of 
the Māori workshops explained, they had 
reframed their views of race and genetics 
on the basis of learning basic knowledge on 
genetics and admixture. 
Genetics is not race based; it’s familial. 
Māori are an admixed population…How do 
you know that that’s our Māori genes? How 
come it’s not our Scottish genes? (Māori key 
informant, workshop).
Because if you look at the Human Genome 
Project, for instance, we’re from the family of 
Maui apparently…It’s pretty much all Poly-
nesian, brown people…but it just seems so 
racialised…They never fi nd bad genes in the 
white population. It’s always in the Māori 
group (Māori key informant, workshop).
Key informants also described how genetic 
analyses rarely recognised the broader 
social context and distracted attention from 
social determinants of health, including the 
impact of colonisation and poverty.
The truth is we didn’t have diabetes before 
we had a western diet, so how can that be 
genetically right? Pakeha get diabetes and 
they get gout so we use prevalence and 
incidence rates to again racialise an illness 
which really is an illness of poverty…In 
genetics they never discuss poverty (Māori 
key informant, workshop).
Control over samples and data
Key informants described the impor-
tance of Māori involvement in decisions 
over access, storage and use of tissue and 
data. They could see the potential for 
Māori participation in genomic research 
shifting from being a subject of research 
and a provider of tissue towards greater 
participation in the research design and 
governance. Control over tissue and data 
ensures that it is used for research that 
directly benefi ts the community and in a 
manner that recognises its cultural signifi -
cance. They spoke about the need for Māori 
to have more infl uence over the use of data 
and the direction of research. 
Stewardship requires access to research 
and data to support developments within our 
communities. Engagement with research is a 
key activity related to accessing quality data 
in support of our aspirations for sovereignty 
(Key informant interview).
Some groups are exercising sovereignty by 
being involved in decisions on genetic research 
and biobanking (Key informant interview). 
Increasing Māori participation in regu-
latory roles and strengthening Māori 
governance was potential mechanisms 
to improve the level of monitoring for 
researchers and biobanks in possession 
of Māori tissue. Possession of tissue was 
viewed as carrying strong implications in 
terms of stewardship and care. Key infor-
mants stated that it is important to be 
involved in the development of policies for 
these groups. 
I think it comes back to accountability 
because whoever owns the keys to the freezer 
typically determines what happens to the 
samples, and if the person who had the keys 
to the freezer is not keeping [researchers] 
accountable to what was agreed on in the 
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fi rst place then really they can do whatever 
they want (Māori key informant, workshop).
With the biobank…you almost need…like a 
Māori with veto powers on a committee that 
evaluates [the research] and says, “Look if 
you don’t use the tissue for the purpose you 
signed up for in the beginning then nothing 
gets published because you…had the ability 
to be able to say I don’t want this published”. 
But I mean an Iwi group won’t have the same 
[power] (Māori key informant, workshop). 
Benefit sharing
Benefi t sharing is an important element 
of the research relationship. Key informants 
recognised that benefi ts would not always 
be direct health improvements but thought 
there was scope to explore other possibilities 
through education, capacity building and 
intellectual property. Ownership of material 
and data was discussed as an issue related 
to potential development of commercial 
products. Key informants stated that both 
researchers and participants can realise 
benefi ts from a project and a balance needs 
to be found to ensure communities receive 
an equitable share of the benefi ts produced 
through genomic research. 
So we need to think about it in the broader 
context, and then there’s the ethics and 
the quality of the research, partnerships...
and negotiation of benefi ts (International 
Advisory Panel).
Expectations of consultation and 
engagement
A desire to protect Māori/Indigenous 
rights and interests through the entire 
process of research informs their expec-
tations of consultation. Key informants 
discussed the place of community 
engagement in the development of projects 
and the need for researchers to talk to 
the right individuals within communities. 
Appropriate consultation will provide an 
opportunity to negotiate issues of research 
design, sampling strategies, language, 
cultural support, research governance, 
review processes and publication protocols. 
Overall the use of appropriate research 
design was seen as a signifi cant factor in 
the protection of Māori and Indigenous 
interests. Key informants spoke about Māori 
values informing the parameters around 
which tissue can be used. Health research 
has a number of best practice models which 
emphasise the importance of early discus-
sions with Iwi/Māori, which is especially 
relevant for this context given the complex 
nature of the studies and the ethical issues 
associated with it. 
This is where having a conversation 
with Iwi becomes really important…We 
have groups that…don’t necessarily know 
what it is they are saying yes to (Māori key 
informant, workshop).
Expectations of consent
Key informants suggested that community 
consent was required to gain support for 
the genomic project taking place. Māori 
communities needed access to someone who 
could ‘translate’ genomic research jargon 
into practical terms for consideration. The 
translator would have the ability to explain 
what the research is likely to provide to 
the community, what will not be provided 
and any risks associated with participation. 
Access to independent resources and guide-
lines would create a more transparent and 
safer process for communities. 
You need somebody on your own team, Iwi 
need someone for themselves that actually 
can broker with the geneticists…you actually 
need someone who can talk the geneti-
cist’s language that actually understands 
what methods should be used (Māori key 
informant, workshop).
If you want to explore that uniqueness of 
a certain collective then you actually have 
to have that collectives consent, that way 
you can go forward...The academic freedom 
is seen as the sort of guiding principle by 
the researcher, like I don’t need to be told 
by some community how to do my science 
(Non-Māori key informant, interview). 
Key informants felt that individual 
consent provides a mechanism to both 
allow participation while also restricting 
certain activities that participants might 
not be comfortable with like sending tissue 
overseas and consent for future use. It is 
important to consider the timing of consent 
and allowing individuals time to discuss 
risks and benefi ts with family and friends. 
The recruitment process is a key part of the 
gaining informed consent. Māori involved 
in the direct recruitment of participants 
often felt their connection to those commu-
nities may have infl uenced peoples’ decision 
to participate more than the information 
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provided. This can create a tension for the 
Māori recruiter who becomes responsible 
for the tissue, in the eyes of the community, 
even if they have no decision-making power 
within the project team. 
Once again, who was the person who was 
getting the consent? It was actually Māori 
to Māori. You’re sitting there, you’re talking 
about it [genetic research project], we’re 
selling it and they’re buying in (Māori key 
informant, science workshop).
To me the biggest lesson I’ve learnt is that 
we shouldn’t say anything. We should put 
them in front of our people and if our people 
don’t like them they say no and then that’s how 
it is (Māori key informant, science workshop).
Ongoing communication and 
feedback
Key informants explained how a lack of 
knowledge is seen as a key factor in creating 
barriers for both researchers and Māori 
participants. Key informants in the science 
workshops perceived that Māori reluctance 
to participate in genomic research is due to 
not knowing how genomic research works 
and that this can also lead to suspicion and 
misunderstanding. They also spoke about 
having a lack of knowledge on how to 
engage with Māori to ensure that effective 
consultation and negotiation is part of 
the process of research and biobanking. 
In contrast, key informants in the Māori 
workshops expressed frustration with the 
lack of feedback and information about the 
progress and outcomes of research projects 
and stated that this reinforced negative 
sentiments about researcher commitment to 
their communities.
Increasing the level of genetic literacy 
was identifi ed as important in the context of 
having communities make more informed 
decisions about participation in genomic 
research. Education initiatives to increase 
awareness were seen as vital for both Māori 
and science communities. Increasing levels of 
cultural literacy within science communities 
should lead to a greater acknowledgement 
and respect for Māori views within the 
research project, enabling researchers to 
develop research questions that align with 
community health priorities, and implemen-
tation of research processes that support 
opportunities for Māori development. 
[Guidance for scientists is important] to 
increase the comfort level of Indigenous 
people who are participants in biobanking 
and genomic research (Māori key informant 
interview, workshop).
Discussion
There are a small number of estab-
lished biobanks in New Zealand that 
manage tissue for research purposes 
including genomic research but a much 
larger number of ‘informal biobanks’, 
research-based tissue collections, which 
have samples that have been consented 
for future use. As there is no register for 
biobanks or research-based tissue collec-
tions there is no way of knowing how 
many samples are in storage or how many 
of them have been provided by Māori 
participants. Few projects have specifi cally 
collected samples from Māori popula-
tions for genomic research, in part due to 
the challenge of ensuring Māori support. 
Notable exceptions include the Gout and 
Related Conditions Project in Ngāti Porou, 
the Rakaipaaka Health and Ancestry Study 
and Te Wai o Rona based in the Waikato. 
While Māori views on genetic research 
and biotechnologies indicate an increasing 
willingness to engage if there is a health 
benefi t for the family or community,11,18,66 it 
was evident in the workshops that commu-
nities are also becoming more critical 
about the nature of participation and 
expectations of researchers. 
Māori communities are often uneasy 
about participating in genomic research, 
based on past experiences where projects 
have operated outside the ethical bound-
aries agreed with communities. Projects led 
by Arizona State University and Institute of 
Environmental Science and Research did 
not end well for Indigenous communities 
and highlight the potential risks associated 
with engagement in genomic research. 
Researchers at Arizona State University 
(ASU) gathered blood samples from Hava-
supai Tribe in Arizona to search for a link 
to diabetes, but used the samples to look 
for other diseases and genetic markers. 
Researchers at the Institute of Environ-
mental Science and Research Ltd initiated 
a Health and Ancestry study with the Ngāti 
Rakaipaaka tribe in New Zealand. The 
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primary researcher was the protagonist of 
the ‘Warrior Gene’ and while this incident 
was not directly associated with the study, 
it led to its demise. Indigenous and Māori 
researchers, and communities themselves 
are becoming increasingly vigilant in their 
expectations of research partners. 
The value of participation
Māori views on the potential benefi ts of 
biobanking, genetics and genomic research 
are largely related to helping others. Māori 
cultural concepts, in particular the concept 
of manaakitanga (caring, kindness), is said 
to increase the likelihood of Māori agreeing 
to participate in genetic research.14 Believing 
that participation will help a family member 
or someone else in the community who is 
unwell is a key motivator for Māori partic-
ipation in health-related biotechnologies.11 
Māori views on the value of partnership 
between Māori communities and genetic 
researchers are shown to be positive if the 
research is seen to be of benefi t, particularly 
in areas such as predictive cancer testing.17 
While there are concerns raised over the 
reductionist nature of genetics, the value of 
genetic testing for Māori may lie in fi nding 
solutions to immediate and severe health 
states18 and through predictive genetic 
tests that identify risks of developing 
disease.17 However, Māori recognise that 
health inequalities may not be adequately 
explained by genetics, and one potential 
consequence of genetic research is that it 
could contribute to diminishing support for 
equity-based policies that recognise the role 
of social justice in relation to inequalities.55 
The challenge of e ective 
participation
The challenges for Māori communities 
in participating effectively in genomic 
research and biobanking projects refl ect 
the broader political dynamic relating to 
Indigenous-State relationships and equitable 
access to resources, including research. 
It traverses the interface between mātau-
ranga Māori and science, and touches on the 
difference between the ‘value’ associated 
with biological tissue, a taonga (treasure) in 
a cultural context and a biological resource 
in the science community. It is informed by 
a diverse range of Māori discourses, expe-
riences and worldviews, and as there are 
numerous opportunities for misinterpre-
tation and misunderstanding, an authentic 
engagement should be underpinned by clear 
processes and values.57 
It is apparent that one of the effects of 
colonisation is a general marginalisation 
of Māori communities within the realms 
of education, limiting Māori capacity and 
capability to engage in research. This is 
especially true for the increasingly technical 
research projects conducted in scientifi c 
disciplines. The Māori key informants 
indicated that there was a general lack of 
understanding about genomic research and 
biobanking in their communities and also 
identifi ed that there were limited oppor-
tunities for involvement in the research 
process. Becoming ‘informed’ is a signif-
icant challenge for both communities 
engaging with researchers and individuals 
considering participation in projects. The 
information imbalance refl ects the power 
imbalance that exists between researchers 
and communities, a situation that can only 
be effectively mediated through the devel-
opment of ethical relationships and use 
of culturally appropriate biobanking and 
research processes.58,59 
The increasingly complex and technical 
nature of genomic research creates chal-
lenges for effective communication between 
communities and researchers. A high degree 
of literacy and understanding is required 
to understand the contexts of the health 
condition, genetics and research for Māori 
communities to engage meaningfully in 
consultation and consent processes. One 
example of education initiatives that inform 
Indigenous communities is the National 
Congress of American Indians Genetics 
Resource Centre. 
The alignment of Māori health priorities 
with scientifi c research agendas is two-fold. 
At a superfi cial level, it is about defi ning the 
scope, aligning the research inquiry with an 
area of Māori health need and identifying the 
potential benefi ts and risks. At a deeper level, 
it is about understanding the contribution 
of the research project to equitable health 
outcomes, which means a greater focus on 
the pathway to implementation, specifi cally 
for Māori communities. Existing inequalities 
in access to and provision of services within 
the health system mean that the devel-
opment of new medicines or treatments does 
not automatically equate to a health gain. 
While the implementation pathway may not 
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be the direct responsibility of the researcher, 
involving Māori communities in determining 
the purpose of the research provides a key 
advocate for its implementation through 
tribal and other health services. Māori key 
informants in workshops indicated that it 
would be important to have the ability to 
steer research processes for Māori interests.
Māori involvement in the governance of 
research programmes provides opportu-
nities for Māori interests to be promoted and 
protected. In the context of biobanks, deci-
sions about the use of Māori tissue samples 
should be made by Māori members or 
committees who can assess the value of the 
proposed project and level of Māori support 
either through individual or collective Iwi 
consent. This oversight is likely to increase 
the level of confi dence of potential donors 
that their tissue will be used in a culturally 
appropriate manner,60 especially in relation 
to the inherent uncertainty associated with 
its ‘future use’ in a changing scientifi c and 
funding environment.
The key informants suggested that the 
overarching goals of any ethical framework 
should both provide a level of ethical 
oversight to protect the interests of partici-
pants and their communities, and educate 
the communities so that they can better 
determine how they might like to engage, or 
not, with genomic research and biobanking 
projects. The important issues that emerged 
from the key informants include;
• Research Purpose: Clarity, alignment 
with community priorities and 
keeping to scope of research question
• Outcomes: Community benefi ts, 
capacity building
• Benefi ts and Risks: Identifi cation, real-
isation/mitigation, coercion
• Researchers talking about the issues 
to the right people at the right levels. 
Levels of engagement include indi-
viduals, communities and experts
• Opportunity to engage: Policies, 
capacity, involvement in design and 
questions, ongoing communication, 
research governance 
• Control/ownership: Samples, data, 
intellectual property
• Governance of sample storage and 
use: Status—mana and wairua, access 
and storage, use and future use
• Governance of data: Use of data, data 
sharing
• Informing consent: Access to tech-
nical advice and support, increase 
in functional literacy, interactivity, 
access to information
• Language: Translation of science 
concepts, cultural contextualising
• Consent: Duration of use of tissue, 
specifi city, timing, process, parameter
• Results: Use, interpretation, contextu-
alisation, presentation
• Application to health service delivery: 
Action
The themes that emerged from this project 
echo issues identifi ed in other Indigenous 
communities. Taualii61 proposed a GREAT 
Research model reiterating the importance 
of Governance, Re-consent, Education, 
Accountability, Transparency, Research 
priorities for Native Hawaiian communities. 
Improved consultation, consent and trans-
parency of research intent, conduct and 
use of specimens and results among Alaska 
Native people was noted by Hiratsuka and 
others.61 Anderson and others62 mapped 
a series of issues complicating Aboriginal 
and Torres Strait Islander participation in 
genetic research, including issues with the 
research process, the research fi ndings and 
the research samples. These studies highlight 
a common Indigenous interest in improving 
the processes of biobanking, genetic research 
and the practices of researchers. 
Enhancing Māori participation in 
biobanking and genomic research 
Various ethical guidelines now reference 
specifi c Indigenous principles and identify 
issues that should be resolved. Taniguchi 
and others64 conducted a comparative 
analysis of Indigenous research guidelines 
for genomic research and found that no 
one document provided comprehensive 
guidance for all the issues. The continuing 
development of Indigenous research guide-
lines will be benefi cial to both communities 
and researchers. Increasing the level of 
involvement in the governance of Indig-
enous biospecimens and genomic data is 
also on the agenda for Indigenous commu-
nities. This not only involves participation 
on governance structures for existing 
biobanks but also encourages the estab-
lishment of more enduring and co-ordinated 
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entities, including Indigenous biorespos-
itories (ie Alaska Area Specimen Bank; 
International Collaborating Centre for Indig-
enous Peoples and Genomic Research, South 
Australian Medical and Health Research 
Institute) and biospecimen networks. 
Governance structures provide a mech-
anism for protecting Māori interests and 
can both strengthen issues of mandate 
and consent as well as allay concerns 
about individual participants’ consent 
being properly informed. This will include 
addressing historic project-based collec-
tions of biological samples that have been 
consented for future use, where the deci-
sion-making power defaults to the principal 
researcher and their institution. There is 
little transparency in relation to the gover-
nance of these research collections, which 
might be considered ‘informal biobanks’ and 
rarely any Māori participation in decisions 
about how the samples get used. The general 
uncertainty about future use provisions 
highlight the trust and accountability in the 
relationships established between research 
teams and communities and the impor-
tance of understanding the role of Māori 
communities in the protective functions of 
governance and consent. Discussions with 
the key informants in the science workshops 
illustrated that some biomedical researchers 
are becoming more aware of the importance 
of cultural protocols and the need to work 
with communities to ensure that research 
processes prevent the misuse of tissue. 
Processes of consent that recognise 
collective decision-making5,43 and dynamic 
consent,65,66 including providing options for 
differential consent (to various components 
of a project or elements of future use) and 
supporting expectations to re-consent for 
future use, are more likely to be mandated 
by Māori and Indigenous communities.61 
Strengthening governance and consent 
processes is also related to capacity 
building within Māori communities. The 
technical nature of genomic research, 
which requires high levels of literacy in 
relation to research, genetics and the health 
condition, are a barrier to public under-
standing. Access to good public education 
resources and targeted support for Māori 
communities will assist them to become 
informed and enhance their contributions 
to the project. The ‘education’ of commu-
nities involves more than just upskilling 
people in the sciences. Māori communities 
hold knowledge that can contribute to 
understanding what is safe, necessary and 
possible in their communities.67 Indeed, 
the advancement of health and wellbeing 
is reliant on the intelligent use of different 
types of knowledge so genomic science, 
public health, indigenous knowledge and 
other disciplines can provide useful contri-
butions to this aim.
Conclusion
Māori views on biobanking and genomic 
research are evolving, as the points of 
engagement between these communities 
and researchers increase with the merging 
of the clinical and research contexts. A 
wide range of views are present in Māori 
communities from actively opposed to 
non-supporting, from ambivalent to 
conditionally supportive. There is a recog-
nition that Māori individuals and whānau 
will engage with genomic research and 
biobanking if it is in their interests and 
that this should be supported within a 
framework that protects the broader 
interests of Māori communities at hapū, Iwi 
and national levels.
A range of concerns were expressed by 
key informants covering issues at individual, 
project and system levels. The protection 
of Māori rights and interests is of primary 
concern, as is the targeting of this type of 
research towards Māori health priorities. 
There was dissatisfaction with current 
engagement and a preference for a greater 
level of consultation and more dynamic 
and inclusive processes of consent. Ongoing 
control over samples and data was iden-
tifi ed as a key consideration, including the 
robustness and interpretation of genomic 
research methods. Informed engagement 
is dependent on the level of knowledge 
about biobanking and genomic research 
highlighting the need for public education 
initiatives as well as ongoing communi-
cation and feedback about specifi c projects.
Effective engagement will not only require 
a more active process of consultation in the 
development of projects but a continuing 
relationship with hapū, Iwi and other Māori 
entities. The ‘model of trust’ which underpin 
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